Matrix metalloproteinases and tissue inhibitors of metalloproteinases in colonic adenomas-adenocarcinomas

Diseases of the Colon and Rectum

Volumn 39, Issue 11, 1996, Pages 1255-1264

  Tomita, Tatsuo ^a   Iwata, Kazushi ^b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b FUJI CHEMICAL INDUSTRIES LTD   (Japan)

Author keywords

Colonic adenocarcinomas; Colonic adenomas; Matrix metalloproteinases; Tissue inhibitors of metalloproteinases

Indexed keywords

COLLAGENASE;

ADULT; AGED; ARTICLE; BASEMENT MEMBRANE; COLON ADENOCARCINOMA; COLON ADENOMA; COLON CARCINOGENESIS; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN TISSUE; MALE; METASTASIS;

EID: 0029912777     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02055119     Document Type: Article

References (46)

1. Liotta LA, Steg PS, Stetler-Stevenson WG. Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 1991;64:327-36.
2. Stetler-Stevenson WG, Sznavoorian S, Liotta LA. Tumor cell interactions with the extracellular matrix during invasion and metastasis. Annu Rev Cell Biol 1993;9:541-73.
3. Woessner JF Jr. Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 1991;5:2145-54.
4. Birkedal-Hansen H, Moore WG, Bodden MK, et al. Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993;42:197-250.
5. Matrisian LM. The matrix-degrading metalloproteinases. Bioessays 1992;14:455-63.
6. Morodomi T, Ogata Y, Sasaruri Y, Morimatsu M, Nagase H. Purification and characterization of matrix metalloproteinase-9 from U937 monocytic leukemia and HT1080 fibrosarcoma cells. Biochem J 1992;285:603-11.
7. Poulsom R, Pignatelli M, Stetler-Stevenson WG, et al. Stromal expression of 72Kda type VI collagenase (MMP-2) and TIMP-2 mRNA in colorectal neoplasia. Am J Pathol 1992;141:389-96.
8. Pyke C, Ralfkiaer E, Tryggvason K, Dano K. Messenger RNA for two type VI collagenases is located in stromal cells in human colon cancer. Am J Pathol 1993;142:359-65.
9. Zucker S, Lysik RM, Zarrabi MH, Moll U. Mr 92,000 type VI collagenase is increased in plasma of patients with colon cancer and breast cancer. Cancer Res 1993;53:140-6.
10. Jaziorka M, Haboubi NY, Schofield PF, et al. Distribution of gelatinase B(MMP-9) and type VI collagen in colorectal carcinoma. Int J Colorectal Dis 1994;9:141-8.
11. Fearson EC, Vogelstein B. A genetic model for colorectal tumorigenesis. Cell 1990;61:759-69.
12. Bell SM, Scott N, Cross D, et al. Prognostic value of p53 overexpression and C-ki-ras gene mutations in colorectal cancer. Gastroenterology 1993;104:57-64.
13. Cattoretti G, Becker MH, Key G, et al. Monoclonal antibodies against recombinant parts of the Ki-67 antigen detect proliferating cells in microwave-processed formalin-fixed paraffin sections. J Pathol 1992;168:357-63.
14. Ogata Y, Pratta MA, Nagase H, Arner EC. Matrix metalloproteinase-9(92-kDa gelatinase/type VI collagenase) is reduced in rabbit articular chondrocytes by cotreatment with interlukin 1 beta and a protein kinase C activator. Exp Cell Res 1992;20:245-9.
15. Astler VB, Coller FA. The prognostic significance of the colon and rectum. Ann Surg 1954;139:846-52.
16. Foulds L. The natural history of cancer. J Chronic Dis 1958;8:2-37.
17. Goekz SE, Vogelstein B, Hamilton SR, Feinberg AP. Hypomethylation of DNA from benign and malignant human colon neoplasms. Science 1985;228:187-90.
18. Vogelstein B, Fearson E, Hamilton S, et al. Genetic alterations during colorectal tumor development. N Engl J Med 1988;319:525-32.
19. Hewitt RE, Leach IH, Powe DG, et al. Distribution of collagenase and tissue inhibitor of metalloproteinases (TIMP) in colorectal tumours. Int J Cancer 1991;49:666-72.
20. D'Errico AD, Garbisa S, Liotta LA, et al. Augmentation of type VI collagenase, laminin receptor, and Ki- 67 proliferation antigen associated with human colon, gastric and breast carcinoma progression. Mod Pathol 1991;4:239-46.
21. Levy AT, Cioce V, Sobel ME, et al. Increased expression of Mr 72,000 type VI collagenase in human colonic adenocarcinoma. Cancer Res 1991;51:439-44.
22. Ogata Y, Enhgild JJ, Nagase H. Matrix metalloproteinase-3 (stromelysin) activates the precursor for the human matrix metalloproteinase-9. J Biol Chem 1992;267:3581-4.
23. Okada Y, Watanabe S, Nakanishi I, et al. Inactivation of tissue inhibitor of metalloproteinases by neutropil elastase and other serine proteinases. FEBS Lett 1988;229:157-60.
24. Okada Y, Morodomi T, Enghikd JJ, et al. Matrix metalloproteinase 2 from human rheumatoid synovial fibroblasts - purification and activation of the precursor and enzyme properties. Eur J Biochem 1990;194:721-30.
25. Ochiai M, Sasaguri Y, Morimatsu M, et al. Effect of linoleic acid hydroperoxide on production of matrix metalloproteinases by human skin fibroblasts. Biochem Int 1991;25:447-52.
26. Kodama S, Iwata K, Yamashita Y, Hayakawa T. Rapid one-step enzyme immunoassay for tissue inhibitor of metalloproteinases. J Immunol Methods 1990;127:103-8.
27. Hembry RM, Bagga MR, Reynolds JJ, Hamblen DL. Stromelysin, gelatinase A and TIMP-1 in prosthetic interface tissue: a role for macrophages in tissue remodelling. Histopathology 1995;27:149-59.
28. Davies B, Miles DW, Happerfield LC, et al. Activity of type IV collagenases in benign and malignant breast disease. Br J Cancer 1993;67:1126-31.
29. Sato H, Takino T, Okada Y, et al. A matrix metalloproteinase expressed on the surface of invasive tumour cells. Nature 1994;370:61-5.
30. Morson BC, Dawson IM, Day DW, Jass JR, Price AB, Williams GT. Benign epithelial tumours and polyps. In: Morson BC, Dawson IM, eds. Morson and Dawson's gastrointestinal pathology Oxford: Blackwell Scientific, 1990:563-96.
31. McDonnell S, Navre M, Coffey RJ, Matrisian LM. Expression and localization of matrix metalloproteinase PUMP-1(MMP-7) in human gastric and colon carcinomas. Mol Carcinog 1991;4:527-33.
32. Muller D, Breathnach R, Engelman A, et al. Expression of collagenase-related metalloproteinase gene in human lung or head and neck tumours. Int J Cancer 1991;48:550-6.
33. Paine ML, Gibbons JR, Whitelock JM, et al. Unregulated and independent expression of collagenase and transin related to tumor progression. J Natl Cancer Inst 1993;85:1425-7.
34. van der Statten JJ, Hendriks T, Wobbes T. Correlation between collagenolytic activity and grade of histological differentiation in colorectal tumors. Int J Cancer 1990;45:1071-8.
35. Alvarez OA, Carmichael DF, DeClerck YA. Inhibition of collagenolytic activity and metastasis of tumor cells by a recombinant human tissue inhibitor of metalloproteinases. J Natl Cancer Inst 1990;82:589-95.
36. Albini A, Melchiori A, Santi L, Liotta LA. Tumor cell invasion inhibited by TIMP-2. J Natl Cancer Inst 1991;83:775-9.
37. DeClerck YA, Perez N, Shimada H, et al. Inhibition of invasion and metastasis in cells transfected with an inhibitor of metalloproteinases. Cancer Res 1992;52:701-8.
38. Nagase H. Matrix metalloproteinase. In: Hooper NM, ed. Zinc metalloproteinases in health and disease. Ellis Horwood, West Susex (in press).
39. Gasson JC, Golde DW, Kaufman SE, et al. Molecular characterization and expression of the gene encoding human erythroid-potentiating activity. Nature 1985;315:768-71.
40. Hayakawa T, Yamashita K, Tanzawa K, et al. Growth-promoting activity of tissue inhibitor of TIMP-1 for a wide range of cells. FEBS Lett 1992;298:29-32.
41. DeClerck YA, Yean TD, Lu HS. Inhibition of autoproteolytic activation of interstitial procollagenase by recombinant metalloproteinase inhibits M1/TIMP-2. J Biol Chem 1991;266:3893-9.
42. Howard EW, Bullen EC, Banda MJ. Regulation of the autoactivation of human 72 kDa progelatinase by tissue inhibitor of metalloproteinase-2. J Biol Chem 1991;266:13064-9.
43. Howard EW, Bullen EC, Banda MJ. Preferential inhibition of 72- and 92 kDa gelatinases by TIMP-2. J Biol Chem 1991;266:13070-5.
44. Stearns ME, Wang M. Type IV collagenase(Mr 72,000) expression in human prostate: benign and malignant tissue. Cancer Res 1993;53:878-83.
45. Lokeshwar BL, Selzer MG, Block NL, Gunja-Smith Z. Secretion of matrix metalloproteinases and their inhibitors by human prostate in explant culture: reduced TIMP secretion by malignant tissue. Cancer Res 1993;53:4493-8.
46. Emmert-Buck MR, Roth MJ, Zhuang Z, et al. Increased gelatinase A(MMP-2) and cathepsin B activity in invasive tumor regions of human colon cancer samples. Am J Pathol 1994;145:1285-90.